Analyst Ratings for Qiagen NV (QGEN) [Neutrals]
QGEN Rating Summary
QGEN Price Target Summary
- Highest: $20.00 (Leerink Swann)
- Lowest: $15.00 (Mizuho Securities)
- Average: $18.00
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$18.00 (-2.8%)
Avg. $ Target:
$18.00 (-2.8%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/1/2013 | Barclays | Downgrade | Equalweight (Overweight) |
19.00 (21.00) |
19.88 | 18.51 | -6.89% | Details |
| 12/17/2012 | BofA/Merrill Lynch | New Coverage | Neutral (N/A) |
20.00 (N/A) |
17.60 | 18.51 | 5.17% | Details |
| 7/2/2012 | Goldman Sachs | Upgrade | Neutral (Sell) |
17.00 (15.00) |
16.70 | 18.51 | 10.84% | Details |
| 9/29/2011 | Mizuho Securities | Downgrade | Neutral (N/A) |
15.00 (N/A) |
14.11 | 18.51 | 31.18% | Details |
| 7/25/2011 | Wedbush | Downgrade | Neutral (N/A) |
19.00 (N/A) |
17.88 | 18.51 | 3.52% | Details |
| 5/11/2011 | Macquarie | Downgrade | Neutral (N/A) |
N/A (N/A) |
21.29 | 18.51 | -13.06% | Details |
| 4/1/2011 | William Blair | New Coverage | Market Perform (N/A) |
N/A (N/A) |
20.05 | 18.51 | -7.68% | Details |
| 3/31/2011 | GARP Research » Updated 5/2/2012 |
Downgrade | Neutral (N/A) |
N/A (N/A) |
20.26 | 18.51 | -8.64% | Details |
| 1/19/2011 | Exane BNP Paribas | Downgrade | Neutral (N/A) |
N/A (N/A) |
19.24 | 18.51 | -3.79% | Details |
| 12/16/2010 | Jefferies | Downgrade | Hold (N/A) |
N/A (N/A) |
19.77 | 18.51 | -6.37% | Details |
| 10/25/2010 | Morgan Stanley | New Coverage | Equalweight (N/A) |
N/A (N/A) |
18.52 | 18.51 | -0.05% | Details |
